Drug Shortages Leave Cancer Patients at Risk

(MedPage Today) — A shortage of paclitaxel (Taxol), a chemotherapy workhorse for ovarian, breast, lung, and colon cancers, demonstrates once again how vulnerable U.S. hospitals and clinics are to an increasingly unreliable pharmaceutical supply chain, leaving patients at risk.

Post a Comment

Comments are closed.